🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we announced our third quarter financial results. Read more in our press release: bit.ly/3YMgL5f

Happy Holidays from our team! We are thankful for all those who have supported us in our mission to advance potentially life-saving therapeutics.

We appreciate our Sperobes' work and dedication in 2024, and look forward to further development of potential treatments to address unmet medical needs in 2025.

Happy New Year from us Sperobes! As we welcome 2025, we're motivated by the potential to develop therapies to improve our patients' quality of life. Here's to a year filled with progress and success!

This #GivingMonth, we hosted a donation drive to collect items for Harvard Square Homeless Shelter and HopeWell Inc. We’re proud to support local organizations providing resources and support to individuals and children in need.

This International Day of Women and Girls in Science, we proudly celebrate the remarkable contributions of #WomenInSTEM! The women on our team are vital to driving innovation and revolutionizing progress in healthcare. Learn more about our values: sperotherapeutics.com/about-us#secti…

Esther Rajavelu, our Interim CEO, will share a corporate presentation at the 45th Annual TDCowen HealthCare Conference on March 4th at 3:10 PM ET. For the webcast link, check our IR page at sperotherapeutics.com/investor-relat…

This month, we honor the incredible women who have shaped history and continue to inspire us every day. At Spero Therapeutics, we are proud to support and empower women in science, technology, and healthcare. #WomensHistoryMonth

Today we announced our fourth quarter and year-end 2024 financial results. We look forward to continuing to advance novel treatments for patients in need. Read more here: s3.amazonaws.com/b2icontent.irp…

Today our team joined forces with the Charles River Conservancy to clean up park areas along the Charles River in Cambridge! Caring for our green spaces keeps our city vibrant, healthy, and welcoming for all. #SperoTherapeutics #EarthDay2025 #CharlesRiverConservancy

Spero announces that Esther Rajavelu will serve as President and Chief Executive Officer, effective May 2, 2025, and will be nominated for election as a member of the Board of Directors. Please see the recent press release for additional information. s3.amazonaws.com/b2icontent.irp…

Today we announced our first quarter 2025 financial results. We look forward to continuing to advance novel treatments for patients in need. Read more here: s3.amazonaws.com/b2icontent.irp…

#News for #Media and #Investors: Today we are announcing with Spero Therapeutics an update on the Phase III trial of one of our investigational oral anti-infectives, following a recommendation by an Independent Data Monitoring Committee. Learn more: gsk.to/3HfBPMj

#BIO2025 is almost here! Our team is excited to meet with other industry leaders to discuss the latest in #Biotech, #DrugDevelopment, #RareDisease & more. Reach out if you'd like to connect!

ICYMI: Big milestone for Spero, with GSK! The Phase 3 PIVOT-PO trial for tebipenem HBr—an investigational oral treatment for cUTIs including pyelonephritis—met its primary endpoint and is stopping early due to efficacy. A major step in the fight against cUTIs.